Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70377-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 70377-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Container-100-mg-vial (100 mg Vial Container)

Container-100-mg-vial (100 mg Vial Container)
This is a description of Micafungin for Injection, USP in the form of a single-dose vial containing 100 mg/vial of micafungin. Upon reconstitution, each milliliter (mL) has 20 mg of micafungin. It is meant for intravenous infusion only. The vial should be discarded if any portion is left unused. The formulation includes micafungin sodium, lactose monohydrate for pH adjustment, and other ingredients. Detailed instructions for dosage, reconstitution, and dilution can be found in the package insert. Storage should be at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). The product is light-protected, preservative-free, and sterile. It is manufactured by Immacule Lifesciences Pvt. Ltd. in India and is distributed by Biocon Pharma Inc. in the USA.*
FDA Label Image

Container-50-mg-vial (50 mg Vial Container)

Container-50-mg-vial (50 mg Vial Container)
This is a description of a medication called Micafungin for Injection. Each vial contains 50 mg of micafungin after reconstitution. It is meant for Intravenous Infusion only. The vial also contains sodium USP, lactose monohydrate, and other ingredients. The medication should be stored at 25°C with excursions permitted between 15°C to 30°C. It is preservative-free and sterile. It is manufactured by Immacule Lifesciences Pvt. Ltd in India. Follow package insert instructions for dosage, reconstitution, and dilution.*
FDA Label Image

Micafungin Sodium Structural Formula (Image 01)

Micafungin Sodium Structural Formula (Image 01)
FDA Label Image

Carton 50 mg/vial (Image 02)

Carton 50 mg/vial (Image 02)
The text contains information about Micafungin for Injection, USP. It includes details about the dosage, storage conditions, reconstitution instructions, and manufacturer information. Micafungin is a medication used for intravenous infusion and comes in single-dose vials. The text also mentions that the medication is sterile, nonpyrogenic, preservative-free, and should be protected from light. Additionally, it provides guidelines for discarding any unused portion of the medication. The product details include the amount of micafungin in each vial and the ingredients present in the solution.*
FDA Label Image

Carton 100 mg/vial (Image 03)

Carton 100 mg/vial (Image 03)
This text contains details about Micafungin for Injection, USP in a 100 mg/vial single-dose vial intended for intravenous infusion only. It provides instructions on storage conditions, reconstitution, dilution, and discarding unused portions. The product contains Micafungin Sodium USP and lactose monohydrate along with other components. The text includes important information like NDC number, expiration date, lot number, manufacturer details, and codes for tracking.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.